Status:
COMPLETED
Patient Forward Access to Clinical and Technological Research: Genetic Influences on Cancer and Atopic Dermatitis
Lead Sponsor:
Boston Children's Hospital
Collaborating Sponsors:
Pfizer
Conditions:
Eczema/Atopic Dermatitis
Cancer
Eligibility:
All Genders
Brief Summary
This Patient Forward study intends to conduct research to investigate potential genetic factors causing cancer and eczema/atopic dermatitis. The study utilizes a patient-centered design and is led by ...
Detailed Description
Inspire will survey its members who have eczema/atopic dermatitis or have had cancer to identify patients that match the health criteria for the study including 1) a diagnosis of one of the two diseas...
Eligibility Criteria
Inclusion
- Having a diagnosis of eczema or atopic dermatitis and/or being related to a person with such a diagnosis
- Having a past diagnosis of cancer and/or being related to a person with such a diagnosis
Exclusion
- Not having such a diagnosis and/or not be related to such an individual
Key Trial Info
Start Date :
February 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04362852
Start Date
February 1 2020
End Date
December 31 2021
Last Update
May 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Children's Hopsital
Boston, Massachusetts, United States, 02115